Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
Ehrenreich H, Degner D, Meller J, Brines M, Béhé M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Brück W, Rüther E, Cerami A, Becker W, Sirén AL.
Ehrenreich H, et al.
Mol Psychiatry. 2004 Jan;9(1):42-54. doi: 10.1038/sj.mp.4001442.
Mol Psychiatry. 2004.
PMID: 14581931
Clinical Trial.